Colangelo Dominick

Vericel CEO Colangelo sold 28,125 shares (9.7% of holdings) over 2 days for $1.2M; stock now 31.3% below 52-week high amid net income losses.

Dominick Colangelo, President and CEO, executed 2 separate sales totaling 28,125 shares for $1,178,155.89 at blended average price $41.89 on 2025-05-14 and 2025-05-15. This represents a 9.7% reduction in his holdings. The sales occurred as the stock trades 31.3% below its 52-week high of $61.80 and the company reported a net income loss of $11,246,000.00 in the latest quarter despite 20.1% annual revenue growth. His prior trades at VCEL show a 0 of 1 well-timed rate at the 90-day mark, with his most recent measurable sale on 2024-11-14 returning +3.9% over 90 days—indicating the stock rose after his sale. Current context reveals elevated operational losses and depressed valuation, but his recent same-ticker sales history at VCEL does not demonstrate well-timed exits at this ticker.

VCEL CEO Colangelo sells 49,700 shares for $2,062,550.00 in two transactions; stock down -30.7% in 90 days.

Dominick Colangelo, President and CEO of Vericel Corp, executed 2 separate sales totaling 49,700 shares for $2,062,550.00 on April 9–10, 2025, at prices of $41.11 and $41.89, representing a -16.0% reduction in his post-transaction holdings to 260,354 shares. The timing follows a sharp 90-day decline of -30.7% from the 52-week high of $61.80, with VCEL trading at $41.25 (current), -33.2% from its annual peak. His prior trades at VCEL show poor 90-day timing: 0 of 3 measurable prior sales at this ticker were well-timed (stock rose after, not fell), and his cross-ticker track record shows an avg 90d return of +9.6% after sells, indicating his sells typically preceded gains rather than declines. The stock's steep recent decline and elevated P/E of 121.32 against negative net income of $-901,000.00 in the latest quarter warrant investor attention to underlying operational health relative to valuation.

CEO Dominick Colangelo sold 53,183 shares (~17% of holdings) for $2.4M at blended avg $46.04 over 2025-03-12/13

Colangelo executed 2 separate sales totaling 53,183 shares for $2,448,810.97 on March 12–13, reducing his stake from 313,180 to 259,997 shares. The blended average price of $46.04 sits well above the current price of $45.38, and significantly above the 52-week low of $40.05, suggesting the CEO sold into strength. His prior 5 trades at VCEL showed mixed results—3 of 5 delivered positive 90-day returns (ranging +3.5% to +42.7%), but the timing pattern is neutral: 0 of 5 prior same-ticker sells were well-timed at the 90-day mark. The company reports a -26.6% drawdown from its 52-week high and faces fundamental headwinds including a loss position (net income $-901.0K) despite +20.1% annual revenue growth. The sale merits monitoring given the stock's recent -19% and -21% declines over 30 and 90 days, though the lack of a scheduled 10b5-1 plan FLAG and the absence of coordinated insider activity suggest this is discretionary rather than pre-arranged.

VCEL CEO Colangelo sells 35,000 shares ($1.9M) in 2 transactions at $55.57 and $53.93; stock now $52.48.

Dominick Colangelo, President and CEO, executed 2 separate sales totaling 35,000 shares for $1,916,250.00 on November 13–14, 2024, at blended average price of $54.75—near the 52-week high of $56.78. Post-transaction, he retains 220,937 shares (a 13.7% reduction). The timing is notable: the stock has advanced +27.2% over the prior 30 days and +13.4% over 90 days, yet his prior trades at VCEL show only 1 of 5 measurable same-ticker outcomes well-timed at the 90-day horizon (a 0% well-timed rate). The company carries significant headwinds: annualized P/E of 749.71, net income of $-901,000.00 over the latest quarter, and full-year unprofitability, despite +20.2% annual revenue growth. The sales occurred at elevated valuation levels following a strong recent rally, in a company with deteriorating profitability metrics.

VCEL CEO Colangelo sold 35,000 shares for $1,430,100 across 2 days; stock down 22.2% from 52-week high, company unprofitable.

Dominick Colangelo, President and CEO of Vericel Corp, conducted 2 separate sales totaling 35,000 shares ($1,430,100.00) on 2024-10-16 and 2024-10-17 at blended average price $40.86, reducing his holdings by -13.7%. The transactions occurred as VCEL traded at $41.66, down 22.2% from its 52-week high of $53.56 and down 10.1% over the prior 30 days. Colangelo's prior 5 trades at VCEL show a pattern of recent selling activity (4 of the last 5 trades were sells on consecutive days in August and September), with the most measurable 90-day outcome showing a -19.7% return from the 2024-07-18 sale. The company's most recent quarter reported revenue of $52,662,000.00 but net income of $-4,682,000.00, with the company unprofitable over its full fiscal year despite posting annual revenue growth of +20.2%. His cross-ticker track record shows an average 90-day return of +4.6% on prior sells across all tickers, with a 43.75% well-timed rate, though same-ticker timing at VCEL has been mixed.

CEO Dominick Colangelo sold 35,000 VCEL shares (13.7% of holdings) in 2 tranches for $1.5M; stock unprofitable with P/E of 2293.50

Dominick Colangelo, President and CEO of Vericel Corp, executed 2 separate sales totaling 35,000 shares for $1,527,225.00 at blended average price $43.64 on September 11–12, 2024, reducing his holdings from 255,937 to 220,937 shares. The company reported net income of $-4,682,000.00 in its latest quarter and remains unprofitable on a full-year basis, while the stock trades at an extremely elevated P/E of 2293.50, reflecting minimal earnings cushion. At the same-ticker level, Colangelo's recent sells show a 0 of 1 well-timed rate at the 90-day mark, with his prior June 2024 sale returning only +1.4% over 90 days; his more recent July and August sales have recorded negative 30-day returns of −10.0% to −10.2%, though longer-term outcomes remain unmeasurable. The current stock price of $45.87 is 14.4% below its 52-week high of $53.56, creating context for evaluating this CEO-level sale against the company's fundamental weakness and the insider's mixed prior timing at this ticker.

CEO Dominick Colangelo sold 35,000 VCEL shares for $1,599,675.00 in two transactions; stock down 12.5% from 52-week high.

Dominick Colangelo, President and CEO of Vericel Corp, executed two separate sales totaling 35,000 shares for $1,599,675.00 on August 14–15, 2024, reducing his holdings from 255,937 to 220,937 shares (a 13.7% reduction of pre-transaction holdings). The blended average sale price of $45.70 is 1.2% below the current price of $46.28 but reflects execution during recent weakness: the stock is currently 12.5% below its 52-week high of $52.90 and has fallen 10.5% over the prior 30 days. At the company level, Vericel remains unprofitable (net income of $-4.7M on quarterly revenue of $52.7M) despite strong annual revenue growth of 20.2%; the valuation multiple (P/E of 2314.00) reflects the negative earnings. Colangelo's prior trade history at VCEL shows mixed timing outcomes: 1 of 1 measurable 90-day outcomes was well-timed (the May 2024 sale preceded a 5.3% decline), but two of the most recent four sales (July and June 2024) returned positive 30-day results, suggesting the recent selling window has not yet validated as a decline. This filing warrants attention given the CEO's continued discretionary selling into a stock down sharply from its recent highs, paired with the company's ongoing unprofitability.

VCEL CEO Colangelo sells 35,000 shares ($1.8M) across 2 transactions at $51.40–$51.55, down 5.3% from 52-week high; unprofitable company.

Dominick Colangelo, President and CEO of Vericel Corp, executed 2 separate sales totaling 35,000 shares for $1,801,625.00 on 2024-07-17 and 2024-07-18 at a blended average price of $51.48. This represents a -13.7% reduction in his post-transaction holdings of 220,937 shares. The timing occurs while the stock is -5.3% from its 52-week high of $52.90 and following a strong 30-day run of +15.5%, suggesting the sales coincided with recent momentum. Notably, Vericel remains unprofitable (net income $-3.9M) and the company's P/E ratio of 5011.00 reflects earnings distortion due to losses; revenue growth of +20.2% year-over-year is offset by ongoing operating losses. At the same-ticker level, Colangelo's prior 5 trades at VCEL showed mixed timing results, with only 1 measurable 90-day outcome (a sell in April 2024 that was well-timed at +16.0%). The current sales warrant examination of whether they reflect opportunistic execution near recent highs or response to fundamental business dynamics.

CEO Dominick Colangelo sold 35,000 VCEL shares for $1,526,350 over 2 days; stock down 20.1% from 52-week high

Colangelo, Vericel's President and CEO, executed 2 separate sales totaling 35,000 shares (35.0K shares) for $1,526,350.00 on consecutive days (June 12-13, 2024) at a blended average price of $43.61, reducing his holdings by 13.7% to 220,752 shares. The sales occurred when VCEL was already down 20.1% from its 52-week high of $52.90 and down 14.4% over the prior 30 days, reflecting deteriorating near-term momentum. Vericel is currently unprofitable (net income of $-3.9M in the latest quarter, with full-year FY net income negative) despite 20.2% annual revenue growth, presenting a mixed fundamental picture. At his cross-ticker track record level, Colangelo's 14 prior sales averaged a 15.8% gain over 90 days post-sale (20.00% well-timed rate), but his 5 prior VCEL-specific sales show inconsistent timing—only 1 of measurable outcomes was well-timed at the 90-day mark, with a recent May 2024 sale already down 14.9% at 30 days. The current filing's consecutive-day execution and the stock's ongoing weakness suggest he may be responding to recent price momentum rather than executing a structured plan.